{"id":"https://openalex.org/W4382240741","doi":"https://doi.org/10.1158/2767-9764.23587248","title":"FIGURE 2 from Adjuvant Therapy with Oncolytic Adenovirus Delta-24-RGDOX After Intratumoral Adoptive T-cell Therapy Promotes Antigen Spread to Sustain Systemic Antitumor Immunity","display_name":"FIGURE 2 from Adjuvant Therapy with Oncolytic Adenovirus Delta-24-RGDOX After Intratumoral Adoptive T-cell Therapy Promotes Antigen Spread to Sustain Systemic Antitumor Immunity","publication_year":2023,"publication_date":"2023-06-27","ids":{"openalex":"https://openalex.org/W4382240741","doi":"https://doi.org/10.1158/2767-9764.23587248"},"language":"en","primary_location":{"id":"doi:10.1158/2767-9764.23587248","doi":"https://doi.org/10.1158/2767-9764.23587248","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.23587248","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2767-9764.23587248","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066812528","display_name":"Hong Jiang","orcid":"https://orcid.org/0000-0003-4668-5319","observed_orcids":["https://orcid.org/0000-0003-4668-5319"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hong Jiang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4668-5319","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029984506","display_name":"Dong Ho Shin","orcid":"https://orcid.org/0000-0002-0135-0817","observed_orcids":["https://orcid.org/0000-0002-0135-0817"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dong Ho Shin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0135-0817","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011969553","display_name":"Yanhua Yi","orcid":"https://orcid.org/0009-0007-2256-9192","observed_orcids":["https://orcid.org/0009-0007-2256-9192"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yanhua Yi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0007-2256-9192","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008880709","display_name":"Xuejun Fan","orcid":"https://orcid.org/0009-0001-4648-0287","observed_orcids":["https://orcid.org/0009-0001-4648-0287"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xuejun Fan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0001-4648-0287","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066614473","display_name":"Joy Gumin","orcid":"https://orcid.org/0009-0004-1057-1285","observed_orcids":["https://orcid.org/0009-0004-1057-1285"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joy Gumin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-1057-1285","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075404207","display_name":"Jiasen He","orcid":"https://orcid.org/0000-0001-7479-4315","observed_orcids":["https://orcid.org/0000-0001-7479-4315"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jiasen He","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7479-4315","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071432456","display_name":"Andrew Gregg Gillard","orcid":"https://orcid.org/0000-0002-9704-7459","observed_orcids":["https://orcid.org/0000-0002-9704-7459"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew G. Gillard","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9704-7459","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026241338","display_name":"Frederick F. Lang","orcid":"https://orcid.org/0000-0003-3747-873X","observed_orcids":["https://orcid.org/0000-0003-3747-873X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frederick F. Lang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3747-873X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071050572","display_name":"Candelaria Gomez\u2010Manzano","orcid":"https://orcid.org/0000-0002-1259-2133","observed_orcids":["https://orcid.org/0000-0002-1259-2133"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Candelaria Gomez-Manzano","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1259-2133","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5038824430","display_name":"Juan Fueyo-Margareto","orcid":"https://orcid.org/0000-0001-6941-2335","observed_orcids":["https://orcid.org/0000-0001-6941-2335"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juan Fueyo","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6941-2335","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.5708000063896179,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.5708000063896179,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.41019999980926514,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oncolytic-adenovirus","display_name":"oncolytic adenovirus","score":0.878000020980835},{"id":"https://openalex.org/keywords/ot-i-t-cells","display_name":"OT-I T cells","score":0.8709999918937683},{"id":"https://openalex.org/keywords/systemic-antitumor-immunity","display_name":"systemic antitumor immunity","score":0.9520000219345093},{"id":"https://openalex.org/keywords/tumor-regression","display_name":"tumor regression","score":0.8759999871253967},{"id":"https://openalex.org/keywords/gp100","display_name":"gp100","score":0.9010000228881836},{"id":"https://openalex.org/keywords/ova","display_name":"ova","score":0.9070000052452087},{"id":"https://openalex.org/keywords/tumor-rechallenge","display_name":"tumor rechallenge","score":0.5830000042915344},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.3970000147819519}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5582395195960999},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.49860668182373047},{"id":"https://openalex.org/C2777785397","wikidata":"https://www.wikidata.org/wiki/Q492194","display_name":"Group B","level":2,"score":0.42130327224731445},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3262965977191925},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.309686541557312},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.25331658124923706}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/2767-9764.23587248","doi":"https://doi.org/10.1158/2767-9764.23587248","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.23587248","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/2767-9764.23587248.v1","doi":"https://doi.org/10.1158/2767-9764.23587248.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.23587248.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2767-9764.23587248","doi":"https://doi.org/10.1158/2767-9764.23587248","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.23587248","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4382240976","https://openalex.org/W4382241062","https://openalex.org/W4382240919","https://openalex.org/W4362473018","https://openalex.org/W4382241179","https://openalex.org/W3182409827","https://openalex.org/W4382240611","https://openalex.org/W4282918377","https://openalex.org/W4382240671","https://openalex.org/W3211351420"],"abstract_inverted_index":{"Systemic":[0],"tumor":[1,29],"regression":[2],"sustained":[3],"by":[4],"combining":[5],"TAA-specific":[6],"T":[7],"cells":[8,117],"and":[9,26,32,140,146,170],"Delta-24-RGDOX":[10],"in":[11],"localized":[12],"intratumoral":[13],"treatment.":[14],"A,":[15],"A":[16],"cartoon":[17],"depiction":[18],"of":[19,28,43,46,57,89,138],"the":[20,44,47,50,58,75,96,113,132],"treatment":[21,52,59,154],"scheme":[22],"for":[23,68,85,150],"schedule":[24],"(left)":[25],"positions":[27],"implantation,":[30],"T-cell":[31],"virus":[33],"injection":[34],"(right).":[35],"s.c.:":[36],"subcutaneously;":[37],"i.t.:":[38],"intratumorally.":[39],"B,":[40],"Spaghetti":[41],"plots":[42,56,149],"volume":[45],"tumors":[48,80,97,114,121],"from":[49,74,98,115,152],"indicated":[51,76],"groups.":[53,60],"C,":[54],"Survival":[55,148],"n":[61,65,163,167,175,179],"=":[62,66,164,168,176,180],"10":[63],"except":[64],"8":[67,107],"PBS.":[69],"D,":[70],"The":[71,129],"cell":[72,77,111,127],"lysates":[73],"lines":[78],"or":[79,92,100],"were":[81,103,119],"analyzed":[82],"with":[83,159],"immunoblotting":[84],"OVA":[86,141],"(the":[87],"target":[88],"OT-I":[90,110,116,126],"cells)":[91],"gp100.":[93],"Note":[94],"that":[95],"PBS":[99],"RGDOX":[101],"group":[102,118],"treated":[104],"ones":[105],"collected":[106,122],"days":[108,124],"after":[109,125,155],"injection;":[112],"relapsed":[120],"32":[123],"injection.":[128],"numbers":[130],"on":[131],"bottom":[133],"represent":[134],"relative":[135],"expression":[136],"levels":[137],"gp100":[139],"normalized":[142],"against":[143],"GAPGH.":[144],"E":[145],"F,":[147],"survivors":[151],"combination":[153],"being":[156],"first":[157],"rechallenged":[158],"B16-OVA":[160],"(D;":[161],"na\u00efve:":[162,174],"4;":[165],"survivor:":[166,178],"6)":[169,181],"then":[171],"CMT64":[172],"(E;":[173],"5;":[177],"cells.":[182],"RGDOX:":[183],"Delta-24-RGDOX.":[184],"ns,":[185],"not":[186],"significant":[187],"(P":[188],">":[189],"0.05);":[190],"*,":[191],"P":[192,196],"<":[193,197],"0.05;":[194],"**,":[195],"0.01.":[198],"log-rank":[199],"test.":[200]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-06-28T00:00:00"}